| Target | cis/trans | Study | SNP | SNP location | Maj/min allele | MAF | N | βinv | seinv | Pinv | fclog | Plog | Praw |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| annexin I | cis | Discovery | rs4745216 | 9:75,744,157 | C/A | 0.04 | 995 | 0.773 | 0.116 | 5.2×10-11 | 1.170 | 4.7×10-11 | 2×10-11 |
| Target (abbrv.) | annexin I |
| Target (full name) | Annexin A1 |
| Somalogic ID (Sequence ID) | SL004208 (4960-72_1) |
| Entrez Gene Symbol | ANXA1 |
| UniProt ID | P04083 |
| UniProt Comment |
|
| Targeted by drugs (based on IPA annotation) |
|
| Biomarker applications (based on IPA annotation) |
|
| Wiki Pathways |
|
| Reactome |
|
All locus annotations are based on the sentinel SNP (rs4745216) and 20 proxy variant(s) that is/are in linkage disequilibrium r2 ≥ 0.8. Linkage disequilibrium is based on data from the 1000 Genomes Project, phase 3 version 5, European population and was retrieved using SNiPA's Block Annotation feature.
Download the detailed results of SNiPA's block annotation (PDF)
| Genes hit or close-by |
|
| Potentially regulated genes |
|
| eQTL genes |
|
| Trait | P | Study | Source |
|---|---|---|---|
| Gene expression of ANXA1 in CEU-CHB-JPT-YRI lymphoblastoid cell lines | 3.3×10-11 | 17873874 (PMID) | GRASP2 eQTL |
| Schizophrenia, bipolar disorder and depression (combined) | 3×10-6 | 20713499 (PMID) | GWAS Catalog via SNiPA |
| Biploar disorder (bipolar II disorder) | 3.3×10-6 | 20713499 (PMID) | GRASP2 nonQTL |
| 2-methoxyacetaminophen sulfate* | 5.6×10-6 | 24816252 (PMID) | gwas.eu via SNiPA |